{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:35:05Z","timestamp":1770334505624,"version":"3.49.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11529-z","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:46:55Z","timestamp":1770288415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the impact of IL-2 cytokine family on skin barrier function: pathophysiology and therapeutic strategies"],"prefix":"10.1007","volume":"53","author":[{"given":"Farzaneh","family":"Kermani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Molaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouya","family":"Goleij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"11529_CR1","doi-asserted-by":"crossref","unstructured":"Rajinikanth SK, Shanmugam L, Anuja AV, Samuel PJ (2022) Interleukin-2. Therapeutic Proteins Against Human Diseases: Springer; pp. 81\u201390","DOI":"10.1007\/978-981-16-7897-4_6"},{"issue":"4","key":"11529_CR2","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","volume":"50","author":"WJ Leonard","year":"2019","unstructured":"Leonard WJ, Lin JX, O\u2019Shea JJ (2019) The \u03b3(c) family of cytokines: basic biology to therapeutic ramifications. Immunity 50(4):832\u2013850","journal-title":"Immunity"},{"issue":"1","key":"11529_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cyto.2011.07.005","volume":"56","author":"SD Katzman","year":"2011","unstructured":"Katzman SD, Hoyer KK, Dooms H, Gratz IK, Rosenblum MD, Paw JS et al (2011) Opposing functions of IL-2 and IL-7 in the regulation of immune responses. Cytokine 56(1):116\u2013121","journal-title":"Cytokine"},{"key":"11529_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.12703\/r\/10-71","volume":"10","author":"AD Keegan","year":"2021","unstructured":"Keegan AD, Leonard WJ, Zhu J (2021) Recent advances in Understanding the role of IL-4 signaling. Fac Reviews 10:71","journal-title":"Fac Reviews"},{"key":"11529_CR5","doi-asserted-by":"crossref","unstructured":"Apert C, Galindo-Albarr\u00e1n AO, Castan S, Detraves C, Michaud H, McJannett N et al (2022) IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4\u2009+\u2009Foxp3+ regulatory T lymphocytes. Front Immunol. ;Volume 13\u20132022","DOI":"10.3389\/fimmu.2022.965303"},{"issue":"1","key":"11529_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mucimm.2024.10.003","volume":"18","author":"F Bick","year":"2025","unstructured":"Bick F, Blanchetot C, Lambrecht BN, Schuijs MJ (2025) A reappraisal of IL-9 in inflammation and cancer. Mucosal Immunol 18(1):1\u201315","journal-title":"Mucosal Immunol"},{"key":"11529_CR7","doi-asserted-by":"crossref","unstructured":"Raval Y, Shaikh M, Dudhat K (2025) From gut to glory: unveiling the microbiome\u2019s impact on human health. Regenerative Eng Translational Med. :1\u201328","DOI":"10.1007\/s40883-025-00412-1"},{"issue":"1","key":"11529_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.det.2016.07.007","volume":"35","author":"TC Scharschmidt","year":"2017","unstructured":"Scharschmidt TC (2017) Establishing tolerance to commensal skin bacteria: timing is everything. Dermatol Clin 35(1):1\u20139","journal-title":"Dermatol Clin"},{"issue":"1","key":"11529_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/imr.13213","volume":"316","author":"J Strobl","year":"2023","unstructured":"Strobl J, Haniffa M (2023) Functional heterogeneity of human skin-resident memory T cells in health and disease. Immunol Rev 316(1):104\u2013119","journal-title":"Immunol Rev"},{"issue":"4","key":"11529_CR10","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/ijms25042021","volume":"25","author":"TT To","year":"2024","unstructured":"To TT, Oparaugo NC, Kheshvadjian AR, Nelson AM, Agak GW (2024) Understanding type 3 innate lymphoid cells and crosstalk with the microbiota: A skin connection. Int J Mol Sci 25(4):2021","journal-title":"Int J Mol Sci"},{"key":"11529_CR11","doi-asserted-by":"crossref","unstructured":"Lockhart A, Mucida D, Bilate AM (2024) Intraepithelial lymphocytes of the intestine. Annu Rev Immunol. ;42","DOI":"10.1146\/annurev-immunol-090222-100246"},{"issue":"10","key":"11529_CR12","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1007\/s12325-022-02241-y","volume":"39","author":"I Turchin","year":"2022","unstructured":"Turchin I, Bourcier M (2022) The role of interleukins in the pathogenesis of dermatological Immune-Mediated diseases. Adv Ther 39(10):4474\u20134508","journal-title":"Adv Ther"},{"key":"11529_CR13","doi-asserted-by":"publisher","first-page":"8816041","DOI":"10.1155\/2021\/8816041","volume":"2021","author":"J Zhao","year":"2021","unstructured":"Zhao J, Lu Q, Liu Y, Shi Z, Hu L, Zeng Z et al (2021) Th17 cells in inflammatory bowel disease: Cytokines, Plasticity, and therapies. J Immunol Res 2021:8816041","journal-title":"J Immunol Res"},{"issue":"9","key":"11529_CR14","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.immuni.2024.07.016","volume":"57","author":"ME Raeber","year":"2024","unstructured":"Raeber ME, Caspar DP, Zurbuchen Y, Guo N, Schmid J, Michler J et al (2024) Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics. Immunity 57(9):2232\u201350e10","journal-title":"Immunity"},{"issue":"1","key":"11529_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cyto.2015.05.008","volume":"75","author":"K Bao","year":"2015","unstructured":"Bao K, Reinhardt RL (2015) The differential expression of IL-4 and IL-13 and its impact on type-2 immunity. Cytokine 75(1):25\u201337","journal-title":"Cytokine"},{"issue":"1","key":"11529_CR16","doi-asserted-by":"publisher","first-page":"G84","DOI":"10.1152\/ajpgi.00192.2006","volume":"292","author":"H Yang","year":"2007","unstructured":"Yang H, Sun X, Haxhija EQ, Teitelbaum DH (2007) Intestinal epithelial cell-derived interleukin-7: A mechanism for the alteration of intraepithelial lymphocytes in a mouse model of total parenteral nutrition. Am J Physiol Gastrointest Liver Physiol 292(1):G84\u201391","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"11529_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4049\/jimmunol.1701603","volume":"201","author":"MD Hu","year":"2018","unstructured":"Hu MD, Ethridge AD, Lipstein R, Kumar S, Wang Y, Jabri B et al (2018) Epithelial IL-15 is a critical regulator of \u03b3\u03b4 intraepithelial lymphocyte motility within the intestinal mucosa. J Immunol 201(2):747\u2013756","journal-title":"J Immunol"},{"issue":"2","key":"11529_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/mi.2007.17","volume":"1","author":"MC Fantini","year":"2008","unstructured":"Fantini MC, Monteleone G, MacDonald TT (2008) IL-21 comes of age as a regulator of effector T cells in the gut. Mucosal Immunol 1(2):110\u2013115","journal-title":"Mucosal Immunol"},{"key":"11529_CR19","doi-asserted-by":"crossref","unstructured":"Dwyer CJ, Knochelmann HM, Smith AS, Wyatt MM, Rangel Rivera GO, Arhontoulis DC et al (2019) Fueling cancer immunotherapy with common gamma chain cytokines. Front Immunol. ;Volume 10\u20132019","DOI":"10.3389\/fimmu.2019.00263"},{"issue":"4","key":"11529_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/JLB.2RI0717-278R","volume":"103","author":"S Mitra","year":"2018","unstructured":"Mitra S, Leonard WJ (2018) Biology of IL-2 and its therapeutic modulation: mechanisms and strategies. J Leukoc Biol 103(4):643\u2013655","journal-title":"J Leukoc Biol"},{"issue":"1","key":"11529_CR21","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.4110\/in.2024.24.e5","volume":"24","author":"J Sprent","year":"2024","unstructured":"Sprent J, Boyman O (2024) Optimising IL-2 for cancer immunotherapy. Immune Netw 24(1):e5","journal-title":"Immune Netw"},{"key":"11529_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/bs.ai.2022.09.002","volume":"156","author":"TA Waldmann","year":"2022","unstructured":"Waldmann TA, Waldmann R, Lin J-X, Leonard WJ (2022) The implications of IL-15 trans-presentation on the immune response. Adv Immunol 156:103\u2013132","journal-title":"Adv Immunol"},{"issue":"1","key":"11529_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","volume":"75","author":"SM McCormick","year":"2015","unstructured":"McCormick SM, Heller NM, Commentary (2015) IL-4 and IL-13 receptors and signaling. Cytokine 75(1):38\u201350","journal-title":"Cytokine"},{"issue":"6","key":"11529_CR24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","volume":"29","author":"CD Surh","year":"2008","unstructured":"Surh CD, Sprent J (2008) Homeostasis of Naive and memory T cells. Immunity 29(6):848\u2013862","journal-title":"Immunity"},{"issue":"1","key":"11529_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12964-020-00538-5","volume":"18","author":"J Wan","year":"2020","unstructured":"Wan J, Wu Y, Ji X, Huang L, Cai W, Su Z et al (2020) IL-9 and IL-9-producing cells in tumor immunity. Cell Communication Signal 18(1):50","journal-title":"Cell Communication Signal"},{"key":"11529_CR26","doi-asserted-by":"crossref","unstructured":"Karnell J, Ettinger R (2012) The interplay of IL-21 and BAFF in the formation and maintenance of human B cell memory. Front Immunol. ;Volume 3\u20132012","DOI":"10.3389\/fimmu.2012.00002"},{"issue":"1","key":"11529_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Therapy 6(1):402","journal-title":"Signal Transduct Target Therapy"},{"issue":"5","key":"11529_CR28","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.4110\/in.2021.21.e33","volume":"21","author":"DH Kim","year":"2021","unstructured":"Kim DH, Kim HY, Lee WW (2021) Induction of unique STAT heterodimers by IL-21 provokes IL-1RI expression on CD8(+) T Cells, resulting in enhanced IL-1\u03b2 dependent effector function. Immune Netw 21(5):e33","journal-title":"Immune Netw"},{"issue":"2","key":"11529_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1189\/jlb.0308149","volume":"84","author":"WJ Leonard","year":"2008","unstructured":"Leonard WJ, Zeng R, Spolski R (2008) Interleukin 21: a cytokine\/cytokine receptor system that has come of age. J Leukoc Biol 84(2):348\u2013356","journal-title":"J Leukoc Biol"},{"key":"11529_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.12703\/r\/10-71","volume":"10","author":"AD Keegan","year":"2021","unstructured":"Keegan AD, Leonard WJ, Zhu J (2021) Recent advances in Understanding the role of IL-4 signaling. Fac Rev 10:71","journal-title":"Fac Rev"},{"issue":"524","key":"11529_CR31","doi-asserted-by":"publisher","first-page":"eaal1253","DOI":"10.1126\/scisignal.aal1253","volume":"11","author":"P Gonnord","year":"2018","unstructured":"Gonnord P, Angermann BR, Sadtler K, Gombos E, Chappert P, Meier-Schellersheim M et al (2018) A hierarchy of affinities between cytokine receptors and the common gamma chain leads to pathway cross-talk. Sci Signal 11(524):eaal1253","journal-title":"Sci Signal"},{"issue":"4","key":"11529_CR32","doi-asserted-by":"publisher","first-page":"2350580","DOI":"10.1002\/eji.202350580","volume":"54","author":"C Sommer","year":"2024","unstructured":"Sommer C, Cohen JN, Dehmel S, Neuhaus V, Schaudien D, Braun A et al (2024) Interleukin-2-induced skin inflammation. Eur J Immunol 54(4):2350580","journal-title":"Eur J Immunol"},{"key":"11529_CR33","doi-asserted-by":"crossref","unstructured":"Barde F, Lorenzon R, Vicaut E, Rivi\u00e8re S, Cacoub P, Cacciatore C et al (2024) Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study. RMD Open. ;10(2)","DOI":"10.1136\/rmdopen-2023-003500"},{"issue":"8","key":"11529_CR34","doi-asserted-by":"publisher","first-page":"e2250359","DOI":"10.1002\/eji.202250359","volume":"53","author":"YH Keith","year":"2023","unstructured":"Keith YH, Egawa G, Honda T, Kabashima K (2023) Mast cells in type 2 skin inflammation: maintenance and function. Eur J Immunol 53(8):e2250359","journal-title":"Eur J Immunol"},{"issue":"4","key":"11529_CR35","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jid.2023.09.284","volume":"144","author":"E Bryan","year":"2024","unstructured":"Bryan E, Teague JE, Eligul S, Arkins WC, Moody DB, Clark RA et al (2024) Human skin T cells express conserved T-Cell receptors that Cross-React with Staphylococcal superantigens and CD1a. J Invest Dermatol 144(4):833\u201343e3","journal-title":"J Invest Dermatol"},{"issue":"1","key":"11529_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/pde.15413","volume":"41","author":"S Basu","year":"2024","unstructured":"Basu S, Barman P, Das J, Kabeerdoss J, Attri SV, Mahajan R et al (2024) Expanding the clinical and immunological phenotype of prolidase deficiency: A case report. Pediatr Dermatol 41(1):115\u2013118","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"11529_CR37","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/acs.jproteome.0c00646","volume":"20","author":"G Castaldo","year":"2021","unstructured":"Castaldo G, Pagano I, Grimaldi M, Marino C, Molettieri P, Santoro A et al (2021) Effect of Very-Low-Calorie ketogenic diet on psoriasis patients: A nuclear magnetic Resonance-Based metabolomic study. J Proteome Res 20(3):1509\u20131521","journal-title":"J Proteome Res"},{"issue":"4","key":"11529_CR38","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jaci.2024.12.1091","volume":"155","author":"AS Quaade","year":"2025","unstructured":"Quaade AS, Litman T, Wang X, Becker C, McCauley BD, S\u00f8lberg JBK et al (2025) Transcriptomic profiling of chronic hand eczema skin reveals shared immune pathways and molecular drivers across subtypes. J Allergy Clin Immunol 155(4):1250\u20131263","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"11529_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12967-023-04293-2","volume":"21","author":"Y Chang","year":"2023","unstructured":"Chang Y, Kang P, Cui T, Guo W, Zhang W, Du P et al (2023) Pharmacological Inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo. J Transl Med 21(1):434","journal-title":"J Transl Med"},{"key":"11529_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.biochi.2020.09.023","volume":"179","author":"A Nadeem","year":"2020","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Alqahtani F, As Sobeai HM et al (2020) Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. Biochimie 179:146\u2013156","journal-title":"Biochimie"},{"issue":"5","key":"11529_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bjd\/ljae495","volume":"192","author":"SL Schell","year":"2025","unstructured":"Schell SL, Sennett ML, Feehan RP, Wallace TE, Meiszberg EC, Longenecker AL et al (2025) Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativa. Br J Dermatol 192(5):845\u2013856","journal-title":"Br J Dermatol"},{"issue":"5","key":"11529_CR42","doi-asserted-by":"publisher","first-page":"100131","DOI":"10.1016\/j.xjidi.2022.100131","volume":"2","author":"LA Beck","year":"2022","unstructured":"Beck LA, Cork MJ, Amagai M, De Benedetto A, Kabashima K, Hamilton JD et al (2022) Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov 2(5):100131","journal-title":"JID Innov"},{"issue":"5","key":"11529_CR43","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jaip.2023.02.005","volume":"11","author":"EH van den Bogaard","year":"2023","unstructured":"van den Bogaard EH, Elias PM, Goleva E, Berdyshev E, Smits JPH, Danby SG et al (2023) Targeting skin barrier function in atopic dermatitis. J Allergy Clin Immunol Pract 11(5):1335\u20131346","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"11529_CR44","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jaci.2023.04.019","volume":"152","author":"N Alkon","year":"2023","unstructured":"Alkon N, Assen FP, Arnoldner T, Bauer WM, Medjimorec MA, Shaw LE et al (2023) Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis. J Allergy Clin Immunol 152(2):420\u2013435","journal-title":"J Allergy Clin Immunol"},{"key":"11529_CR45","doi-asserted-by":"publisher","first-page":"1213138","DOI":"10.3389\/fimmu.2023.1213138","volume":"14","author":"D Wiebe","year":"2023","unstructured":"Wiebe D, Limberg MM, Gray N, Raap U (2023) Basophils in pruritic skin diseases. Front Immunol 14:1213138","journal-title":"Front Immunol"},{"issue":"2","key":"11529_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.alit.2023.01.002","volume":"72","author":"Y Imai","year":"2023","unstructured":"Imai Y (2023) ILC2s in skin disorders. Allergol Int 72(2):201\u2013206","journal-title":"Allergol Int"},{"issue":"6","key":"11529_CR47","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.jaci.2024.06.021","volume":"154","author":"JM Leyva-Castillo","year":"2024","unstructured":"Leyva-Castillo JM, Das M, Strakosha M, McGurk A, Artru E, Kam C et al (2024) IL-4 acts on skin-derived dendritic cells to promote the T(H)2 response to cutaneous sensitization and the development of allergic skin inflammation. J Allergy Clin Immunol 154(6):1462\u201371e3","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"11529_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4049\/jimmunol.2300629","volume":"213","author":"W Zhang","year":"2024","unstructured":"Zhang W, Pajulas A, Niese M, Zhou H, Zhao J, Akhtar N et al (2024) Diminished \u03b3\u03b4 T cells during murine allergic skin inflammation is mediated by IL-4 signaling in keratinocytes. J Immunol 213(2):125\u2013134","journal-title":"J Immunol"},{"issue":"6","key":"11529_CR49","doi-asserted-by":"publisher","first-page":"e70211","DOI":"10.1002\/iid3.70211","volume":"13","author":"AHH Alshihmani","year":"2025","unstructured":"Alshihmani AHH, Mahmoudi M, Kheder RK, Fadaee A, Esmaeili SA (2025) The M2 macrophages importance role in psoriasis. Immun Inflamm Dis 13(6):e70211","journal-title":"Immun Inflamm Dis"},{"key":"11529_CR50","doi-asserted-by":"crossref","unstructured":"Park HJ, Lee SW, Van Kaer L, Lee MS, Hong S (2023) IL-7 deficiency exacerbates atopic dermatitis in NC\/Nga mice. Int J Mol Sci. ;24(12)","DOI":"10.3390\/ijms24129956"},{"issue":"2","key":"11529_CR51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jdermsci.2021.10.001","volume":"104","author":"J Park","year":"2021","unstructured":"Park J, Lee JW, Kim SH, Oh J, Roh WS, Kim SM et al (2021) Type 2 immunity plays an essential role for murine model of allergic contact dermatitis with mixed type 1\/type 2 immune response. J Dermatol Sci 104(2):122\u2013131","journal-title":"J Dermatol Sci"},{"issue":"6","key":"11529_CR52","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1346-8138.15913","volume":"48","author":"K Yamanaka","year":"2021","unstructured":"Yamanaka K, Yamamoto O, Honda T (2021) Pathophysiology of psoriasis: A review. J Dermatol 48(6):722\u2013731","journal-title":"J Dermatol"},{"issue":"2","key":"11529_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaci.2024.10.027","volume":"155","author":"S Sch\u00e4rli","year":"2025","unstructured":"Sch\u00e4rli S, Luther F, Di Domizio J, Hillig C, Radonjic-Hoesli S, Thormann K et al (2025) IL-9 sensitizes human T(H)2 cells to Proinflammatory IL-18 signals in atopic dermatitis. J Allergy Clin Immunol 155(2):491\u2013504e9","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"11529_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/ced.14335","volume":"46","author":"HS Midde","year":"2021","unstructured":"Midde HS, Priyadarssini M, Rajappa M, Munisamy M, Mohan Raj PS, Singh S et al (2021) Interleukin-9 serves as a key link between systemic inflammation and angiogenesis in psoriasis. Clin Exp Dermatol 46(1):50\u201357","journal-title":"Clin Exp Dermatol"},{"key":"11529_CR55","doi-asserted-by":"publisher","first-page":"618897","DOI":"10.3389\/fimmu.2020.618897","volume":"11","author":"Y Tokura","year":"2020","unstructured":"Tokura Y, Phadungsaksawasdi P, Kurihara K, Fujiyama T, Honda T (2020) Pathophysiology of skin resident memory T cells. Front Immunol 11:618897","journal-title":"Front Immunol"},{"key":"11529_CR56","doi-asserted-by":"crossref","unstructured":"Yamaguchi HL, Yamaguchi Y, Peeva E (2023) Role of innate immunity in allergic contact dermatitis: an update. Int J Mol Sci. ;24(16)","DOI":"10.3390\/ijms241612975"},{"key":"11529_CR57","doi-asserted-by":"crossref","unstructured":"Yamaguchi HL, Yamaguchi Y, Peeva E (2024) Pathogenesis of alopecia areata and vitiligo: commonalities and differences. Int J Mol Sci. ;25(8)","DOI":"10.3390\/ijms25084409"},{"issue":"3","key":"11529_CR58","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/jdv.20311","volume":"39","author":"HL Yamaguchi","year":"2025","unstructured":"Yamaguchi HL, Yamaguchi Y, Peeva E (2025) Hair regrowth in alopecia areata and re-pigmentation in vitiligo in response to treatment: commonalities and differences. J Eur Acad Dermatol Venereol 39(3):498\u2013511","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"11529_CR59","doi-asserted-by":"publisher","first-page":"713304","DOI":"10.3389\/fimmu.2021.713304","volume":"12","author":"J Suwanpradid","year":"2021","unstructured":"Suwanpradid J, Lee MJ, Hoang P, Kwock J, Floyd LP, Smith JS et al (2021) IL-27 derived from macrophages facilitates IL-15 production and T cell maintenance following allergic hypersensitivity responses. Front Immunol 12:713304","journal-title":"Front Immunol"},{"issue":"4","key":"11529_CR60","doi-asserted-by":"publisher","first-page":"e2250075","DOI":"10.1002\/eji.202250075","volume":"53","author":"A Mesas-Fern\u00e1ndez","year":"2023","unstructured":"Mesas-Fern\u00e1ndez A, Bodner E, Hilke FJ, Meier K, Ghoreschi K, Solimani F (2023) Interleukin-21 in autoimmune and inflammatory skin diseases. Eur J Immunol 53(4):e2250075","journal-title":"Eur J Immunol"},{"issue":"1","key":"11529_CR61","doi-asserted-by":"publisher","first-page":"e23375","DOI":"10.1096\/fj.202201709RRRR","volume":"38","author":"D Han","year":"2024","unstructured":"Han D, Li F, Zhao Y, Wang B, Wang J, Liu B et al (2024) IL-21 promoting angiogenesis contributes to the development of psoriasis. Faseb J 38(1):e23375","journal-title":"Faseb J"},{"issue":"2","key":"11529_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jid.2020.06.022","volume":"141","author":"AK Clauder","year":"2021","unstructured":"Clauder AK, Kordowski A, Bartsch YC, K\u00f6hl G, Lilienthal GM, Almeida LN et al (2021) IgG Fc N-Glycosylation translates MHCII haplotype into autoimmune skin disease. J Invest Dermatol 141(2):285\u2013294","journal-title":"J Invest Dermatol"},{"issue":"1","key":"11529_CR63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/bjd\/ljaf041","volume":"193","author":"J Gay-Mimbrera","year":"2025","unstructured":"Gay-Mimbrera J, Lozano-Ojalvo D, G\u00f3mez-Arias PJ, Rivera-Ruiz I, Aguilar-Luque M, Moch\u00f3n-Jim\u00e9nez C et al (2025) Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo. Br J Dermatol 193(1):115\u2013124","journal-title":"Br J Dermatol"},{"key":"11529_CR64","doi-asserted-by":"publisher","first-page":"117883","DOI":"10.1016\/j.jep.2024.117883","volume":"326","author":"X Ma","year":"2024","unstructured":"Ma X, Deng G, Tian N, Wang H, Zhao H, Kuai L et al (2024) Calycosin enhances Treg differentiation for alleviating skin inflammation in atopic dermatitis. J Ethnopharmacol 326:117883","journal-title":"J Ethnopharmacol"},{"key":"11529_CR65","doi-asserted-by":"publisher","first-page":"102894","DOI":"10.1016\/j.ceca.2024.102894","volume":"121","author":"PN Gallo","year":"2024","unstructured":"Gallo PN, Mihelc E, Eisert R, Bradshaw GA, Dimek F, Leffler A et al (2024) The dynamic TRPV2 ion channel proximity proteome reveals functional links of calcium flux with cellular adhesion factors NCAM and L1CAM in neurite outgrowth. Cell Calcium 121:102894","journal-title":"Cell Calcium"},{"issue":"5","key":"11529_CR66","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/jid.2013.503","volume":"134","author":"M Omori-Miyake","year":"2014","unstructured":"Omori-Miyake M, Yamashita M, Tsunemi Y, Kawashima M, Yagi J (2014) In vitro assessment of IL-4- or IL-13-Mediated changes in the structural components of keratinocytes in mice and humans. J Invest Dermatology 134(5):1342\u20131350","journal-title":"J Invest Dermatology"},{"key":"11529_CR67","doi-asserted-by":"crossref","unstructured":"Morizane S, Mukai T, Sunagawa K, Tachibana K, Kawakami Y, Ouchida M (2023) Input\/output cytokines in epidermal keratinocytes and the involvement in inflammatory skin diseases. Front Immunol. ;Volume 14\u20132023","DOI":"10.3389\/fimmu.2023.1239598"},{"key":"11529_CR68","doi-asserted-by":"crossref","unstructured":"Napolitano M, di Vico F, Ruggiero A, Fabbrocini G, Patruno C (2023) The hidden Sentinel of the skin: an overview on the role of interleukin-13 in atopic dermatitis. Front Med. ;Volume 10\u20132023","DOI":"10.3389\/fmed.2023.1165098"},{"key":"11529_CR69","doi-asserted-by":"publisher","first-page":"118508","DOI":"10.1016\/j.biopha.2025.118508","volume":"191","author":"Y Che-Wen","year":"2025","unstructured":"Che-Wen Y, Lin F-L, Chen K-H, Cheng Y-P, Cheng Y-C, Guo J-W (2025) Transcriptional dysregulation of skin barrier genes in atopic dermatitis and psoriasis: mechanistic insights and emerging therapeutic strategies. Biomed Pharmacother 191:118508","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"11529_CR70","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/all.15635","volume":"78","author":"A Keren","year":"2023","unstructured":"Keren A, Reich K, Bertolini M, Moga A, Riethm\u00fcller C, Ullmann Y et al (2023) Autologous Th2-polarized lymphocytes induce atopic dermatitis lesions in non-atopic human skin xenotransplants. Allergy 78(6):1538\u20131553","journal-title":"Allergy"},{"issue":"1","key":"11529_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1590\/1414-431x20144047","volume":"48","author":"NN Dang","year":"2015","unstructured":"Dang NN, Pang SG, Song HY, An LG, Ma XL (2015) Filaggrin Silencing by ShRNA directly impairs the skin barrier function of normal human epidermal keratinocytes and then induces an immune response. Braz J Med Biol Res 48(1):39\u201345","journal-title":"Braz J Med Biol Res"},{"issue":"6","key":"11529_CR72","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/jdv.12753","volume":"29","author":"DI Batista","year":"2015","unstructured":"Batista DI, Perez L, Orfali RL, Zaniboni MC, Samorano LP, Pereira NV et al (2015) Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1\/Th2\/Th17 cytokines in adults with atopic dermatitis. J Eur Acad Dermatol Venereol 29(6):1091\u20131095","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"11529_CR73","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jid.2020.09.009","volume":"141","author":"AM Brauweiler","year":"2021","unstructured":"Brauweiler AM, Leung DYM, Goleva E (2021) The transcription factor p63 is a direct effector of IL-4\u2013and IL-13\u2013mediated repression of keratinocyte differentiation. J Invest Dermatology 141(4):770\u2013778","journal-title":"J Invest Dermatology"},{"key":"11529_CR74","unstructured":"D\u2019Avino P, Kim J, Li M, Gessner P, Westermann P, Pat Y et al (2025) Distinct Roles of IL-4, IL-13, and IL-22 in Human Skin Barrier Dysfunction and Atopic Dermatitis. Allergy"},{"issue":"1","key":"11529_CR75","doi-asserted-by":"publisher","first-page":"100309","DOI":"10.1016\/j.xjidi.2024.100309","volume":"5","author":"H Emmert","year":"2025","unstructured":"Emmert H, Rademacher F, H\u00fcbenthal M, Gl\u00e4ser R, Norsgaard H, Weidinger S et al (2025) Type 2 Cytokine\u2013Dependent skin barrier regulation in personalized 2-Dimensional and 3-Dimensional skin models of atopic dermatitis: A pilot study. JID Innovations 5(1):100309","journal-title":"JID Innovations"},{"key":"11529_CR76","doi-asserted-by":"crossref","unstructured":"Grieco T, Paolino G, Moliterni E, Chello C, Sernicola A, Egan CG et al (2025) Transcriptomic profiling of lesional and perilesional skin in atopic dermatitis suggests barrier Dysfunction, inflammatory Activation, and alterations to vitamin D metabolism. Int J Mol Sci. ;26(13)","DOI":"10.3390\/ijms26136152"},{"key":"11529_CR77","doi-asserted-by":"publisher","first-page":"120267","DOI":"10.1016\/j.jep.2025.120267","volume":"352","author":"C Zang","year":"2025","unstructured":"Zang C, Cai M, Chen Q, Yu M, Yan J, Guo Y et al (2025) Elephantopus scaber attenuates MC903-caused atopic dermatitis and decreases TNF-\u03b1\/IFN-\u03b3-induced chemokines by suppressing MKP-1-mediated AP-1 signaling in keratinocytes. J Ethnopharmacol 352:120267","journal-title":"J Ethnopharmacol"},{"key":"11529_CR78","doi-asserted-by":"crossref","unstructured":"Kim HJ, Park M, Jang S, Song HK, Lee SK, Kim T (2025) Pulsatilla Koreana Nakai extract attenuates atopic Dermatitis-like symptoms by regulating skin barrier factors and inhibiting the JAK\/STAT pathway. Int J Mol Sci. ;26(7)","DOI":"10.3390\/ijms26072994"},{"issue":"6","key":"11529_CR79","doi-asserted-by":"publisher","first-page":"e70189","DOI":"10.1111\/srt.70189","volume":"31","author":"YJ Ha","year":"2025","unstructured":"Ha YJ, Tak KH, Lee JL, Kim CW, Ah YC, Kim SS et al (2025) Polynucleotides enhance skin barrier function and reduce inflammation in a 2,4-Dinitrochlorobenzene-Induced mouse model of atopic dermatitis. Skin Res Technol 31(6):e70189","journal-title":"Skin Res Technol"},{"key":"11529_CR80","doi-asserted-by":"crossref","unstructured":"Huang M, Dong L, He Y, Cai X, Lu Y, Xu J et al (2025) YTHDF1 regulates the proliferation and differentiation of keratinocytes via the PI3K\/AKT signaling pathway in atopic dermatitis. Allergology Int","DOI":"10.1016\/j.alit.2025.04.005"},{"issue":"1","key":"11529_CR81","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s00403-025-04168-0","volume":"317","author":"Y Sun","year":"2025","unstructured":"Sun Y, Li X, Deng N, Zhao T, Lv J, Chu J (2025) The role of LINC00114 in atopic dermatitis: modulating inflammation and epidermal barrier dysfunction. Arch Dermatol Res 317(1):662","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"11529_CR82","doi-asserted-by":"publisher","first-page":"e70087","DOI":"10.1111\/exd.70087","volume":"34","author":"MM Guo","year":"2025","unstructured":"Guo MM, Chen KD, Kuo HC (2025) Semaphorin 7a regulates the expression of IL-4 and IL-33 in a cell model of atopic dermatitis and is associated with disease severity. Exp Dermatol 34(3):e70087","journal-title":"Exp Dermatol"},{"issue":"4","key":"11529_CR83","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00109-025-02529-w","volume":"103","author":"RD Correia-Silva","year":"2025","unstructured":"Correia-Silva RD, Corr\u00eaa MP, de Castro ME, Almeida JS, D\u2019\u00c1vila SCGP, Oliani SM et al (2025) Regulatory role of Annexin A1 in NLRP3 inflammasome activation in atopic dermatitis: insights from keratinocytes in human and murine studies. J Mol Med (Berl) 103(4):435\u2013451","journal-title":"J Mol Med (Berl)"},{"issue":"6","key":"11529_CR84","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.jaci.2025.02.035","volume":"155","author":"W Zhang","year":"2025","unstructured":"Zhang W, Dai X, Chen W, Li Y, Mei H, Buddenkotte J et al (2025) Basophil-VAMP7 is a vital regulator of skin barrier integrity and chronic itch. J Allergy Clin Immunol 155(6):1928\u20131944","journal-title":"J Allergy Clin Immunol"},{"key":"11529_CR85","doi-asserted-by":"publisher","first-page":"e2410025","DOI":"10.4014\/jmb.2410.10025","volume":"35","author":"AY Park","year":"2025","unstructured":"Park AY, Lee JO, Jang YN, Kim SY, Heo JH, Kim YJ et al (2025) Ameliorative effects of Escin on inflammation via glucocorticoid receptor (GR) in atopic dermatitis (AD) mouse model. J Microbiol Biotechnol 35:e2410025","journal-title":"J Microbiol Biotechnol"},{"key":"11529_CR86","doi-asserted-by":"publisher","first-page":"1387128","DOI":"10.3389\/fphys.2025.1387128","volume":"16","author":"A Cavallo","year":"2025","unstructured":"Cavallo A, Camera E, Maiellaro M, Bottillo G, Mosca S, Kovacs D et al (2025) Effects of Th1\/Th17 and Th2 cytokines on lipid metabolism in differentiated keratinocytes. Front Physiol 16:1387128","journal-title":"Front Physiol"},{"issue":"6","key":"11529_CR87","doi-asserted-by":"publisher","first-page":"e0026223","DOI":"10.1128\/jvi.00262-23","volume":"97","author":"NC De La Cruz","year":"2023","unstructured":"De La Cruz NC, M\u00f6ckel M, Niehues H, R\u00fcbsam M, Malter W, Zinser M et al (2023) Ex vivo infection of human skin models with herpes simplex virus 1: accessibility of the receptor Nectin-1 during formation or impairment of epidermal barriers is restricted by tight junctions. J Virol 97(6):e0026223","journal-title":"J Virol"},{"issue":"9","key":"11529_CR88","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s13555-025-01479-y","volume":"15","author":"S St\u00e4nder","year":"2025","unstructured":"St\u00e4nder S, Pinter A, Hougeir FG, Guyot P, Xu Y, Praestgaard AH et al (2025) Dupilumab versus lebrikizumab demonstrates greater likelihood of achieving and maintaining improvements in efficacy outcomes using a Placebo-Adjusted indirect treatment comparison. Dermatol Ther (Heidelb) 15(9):2537\u20132551","journal-title":"Dermatol Ther (Heidelb)"},{"key":"11529_CR89","doi-asserted-by":"crossref","unstructured":"de Bruin-Weller MS, Boesjes CM, Achten RA, Beck LA, Irvine AD, Vestergaard C et al (2025) Biologics to treat atopic dermatitis: Effectiveness, Safety, and future directions. Allergy","DOI":"10.1111\/all.70061"},{"issue":"14","key":"11529_CR90","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.3390\/jcm14144960","volume":"14","author":"Y-S Kim","year":"2025","unstructured":"Kim Y-S (2025) Comparative efficacy and safety of tralokinumab and dupilumab in Moderate-to-Severe atopic dermatitis: A narrative review. J Clin Med 14(14):4960","journal-title":"J Clin Med"},{"key":"11529_CR91","doi-asserted-by":"crossref","unstructured":"Junttila IS (2018) Tuning the cytokine responses: an update on Interleukin (IL)-4 and IL-13 receptor complexes. Front Immunol. ;Volume 9\u20132018","DOI":"10.3389\/fimmu.2018.00888"},{"issue":"12","key":"11529_CR92","doi-asserted-by":"publisher","first-page":"9956","DOI":"10.3390\/ijms24129956","volume":"24","author":"HJ Park","year":"2023","unstructured":"Park HJ, Lee SW, Van Kaer L, Lee MS, Hong S (2023) IL-7 deficiency exacerbates atopic dermatitis in NC\/Nga mice. Int J Mol Sci 24(12):9956","journal-title":"Int J Mol Sci"},{"issue":"8","key":"11529_CR93","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2530::AID-IMMU2530>3.0.CO;2-2","volume":"29","author":"LA Wagner","year":"1999","unstructured":"Wagner LA, Brown T, Gil S, Frank I, Carter W, Tamura R et al (1999) The keratinocyte-derived cytokine IL-7 increases adhesion of the epidermal T cell subset to the skin basement membrane protein laminin-5. Eur J Immunol 29(8):2530\u20132538","journal-title":"Eur J Immunol"},{"issue":"1","key":"11529_CR94","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/etm.2016.3263","volume":"12","author":"A Bartlett","year":"2016","unstructured":"Bartlett A, Sanders AJ, Ruge F, Harding KG, Jiang WG (2016) Potential implications of interleukin-7 in chronic wound healing. Exp Ther Med 12(1):33\u201340","journal-title":"Exp Ther Med"},{"issue":"3","key":"11529_CR95","doi-asserted-by":"publisher","first-page":"e33271","DOI":"10.1371\/journal.pone.0033271","volume":"7","author":"N Sismanopoulos","year":"2012","unstructured":"Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Vasiadi M, Therianou A et al (2012) IL-9 induces VEGF secretion from human mast cells and IL-9\/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS ONE 7(3):e33271","journal-title":"PLoS ONE"},{"issue":"5","key":"11529_CR96","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1096\/fj.201801416R","volume":"33","author":"P Kienzl","year":"2019","unstructured":"Kienzl P, Polacek R, Reithofer M, Reitermaier R, Hagenbach P, Tajpara P et al (2019) The cytokine environment influence on human skin-derived T cells. Faseb J 33(5):6514\u20136525","journal-title":"Faseb J"},{"issue":"6","key":"11529_CR97","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000508515","volume":"181","author":"H Karlen","year":"2020","unstructured":"Karlen H, Yousefi S, Simon H-U, Simon D (2020) IL-15 expression pattern in atopic dermatitis. Int Arch Allergy Immunol 181(6):417\u2013421","journal-title":"Int Arch Allergy Immunol"},{"key":"11529_CR98","unstructured":"Mahmood HDJAS (2022) Association between rs3806798 polymorphism of IL-15 gene and its serum level in atopic dermatitis patients. Iraqi J Biotechnol. ;21(2)"},{"issue":"1","key":"11529_CR99","first-page":"47","volume":"119","author":"H Jin","year":"2009","unstructured":"Jin H, Oyoshi MK, Le Y, Bianchi T, Koduru S, Mathias CB et al (2009) IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. J Clin Investig 119(1):47\u201360","journal-title":"J Clin Investig"},{"issue":"2","key":"11529_CR100","doi-asserted-by":"publisher","first-page":"e0148452","DOI":"10.1371\/journal.pone.0148452","volume":"11","author":"NK Patil","year":"2016","unstructured":"Patil NK, Luan L, Bohannon JK, Guo Y, Hernandez A, Fensterheim B et al (2016) IL-15 superagonist expands mCD8\u2009+\u2009T, NK and NKT cells after burn injury but fails to improve outcome during burn wound infection. PLoS ONE 11(2):e0148452","journal-title":"PLoS ONE"},{"issue":"52","key":"11529_CR101","doi-asserted-by":"publisher","first-page":"20024","DOI":"10.1074\/jbc.RA119.010740","volume":"294","author":"W Wong","year":"2019","unstructured":"Wong W, Crane ED, Kuo Y, Kim A, Crane JD (2019) The exercise cytokine interleukin-15 rescues slow wound healing in aged mice. J Biol Chem 294(52):20024\u201320038","journal-title":"J Biol Chem"},{"issue":"3","key":"11529_CR102","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.alit.2016.10.010","volume":"66","author":"H Mizutani","year":"2017","unstructured":"Mizutani H, Tamagawa-Mineoka R, Nakamura N, Masuda K, Katoh N (2017) Serum IL-21 levels are elevated in atopic dermatitis patients with acute skin lesions. Allergol Int 66(3):440\u2013444","journal-title":"Allergol Int"},{"key":"11529_CR103","doi-asserted-by":"crossref","unstructured":"Chen L, Liu C, Xiang X, Qiu W, Guo K (2024) miR\u2013155 promotes an inflammatory response in HaCaT cells via the IRF2BP2\/KLF2\/NF\u2013\u03baB pathway in psoriasis. Int J Mol Med. ;54(5)","DOI":"10.3892\/ijmm.2024.5415"},{"issue":"Pt 2","key":"11529_CR104","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.ijbiomac.2017.05.049","volume":"105","author":"NR Ngatu","year":"2017","unstructured":"Ngatu NR, Motoyama K, Nishimura Y, Okajima MK, Hirota R, Higashi T et al (2017) Anti-allergic and profilaggrin (ProFLG)-mRNA expression modulatory effects of sacran. Int J Biol Macromol 105(Pt 2):1532\u20131538","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"11529_CR105","doi-asserted-by":"publisher","first-page":"9255","DOI":"10.3390\/cimb46090547","volume":"46","author":"J Park","year":"2024","unstructured":"Park J, Shin JY, Kim D, Jun SH, Jeong ET, Kang NG (2024) Dihydroavenanthramide D enhances skin barrier function through upregulation of epidermal tight junction expression. Curr Issues Mol Biol 46(9):9255\u20139268","journal-title":"Curr Issues Mol Biol"},{"issue":"7","key":"11529_CR106","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/medicina59071353","volume":"59","author":"Y Son","year":"2023","unstructured":"Son Y, Yang W, Park S, Yang J, Kim S, Lyu J-H et al (2023) The Anti-Inflammatory and skin barrier function recovery effects of schisandra chinensis in mice with atopic dermatitis. Medicina 59(7):1353","journal-title":"Medicina"},{"key":"11529_CR107","doi-asserted-by":"crossref","unstructured":"Kim J, Lee JM, Park SJ, Nam YR, Choi SW, Nam JH et al (2024) Agrimonia Coreana extract exerts its therapeutic effect through CRAC channel Inhibition for atopic dermatitis treatment. Int J Mol Sci. ;25(16)","DOI":"10.3390\/ijms25168894"},{"key":"11529_CR108","doi-asserted-by":"crossref","unstructured":"Oh JS, Seong GS, Kim YD, Choung SY (2021) Deacetylasperulosidic acid ameliorates Pruritus, immune Imbalance, and skin barrier dysfunction in 2,4-Dinitrochlorobenzene-Induced atopic dermatitis NC\/Nga mice. Int J Mol Sci. ;23(1)","DOI":"10.3390\/ijms23010226"},{"key":"11529_CR109","doi-asserted-by":"publisher","first-page":"156737","DOI":"10.1016\/j.phymed.2025.156737","volume":"141","author":"Y Wu","year":"2025","unstructured":"Wu Y, Wang X-Q, Wu J-Y, Chen Y-J, Bai J-X, Li AS-M et al (2025) A tri-compound formula comprising ginsenoside Rg1, tetrandrine and Icariin alleviates atopic dermatitis symptoms in a mouse model. Phytomedicine 141:156737","journal-title":"Phytomedicine"},{"key":"11529_CR110","doi-asserted-by":"publisher","first-page":"394632024130386","DOI":"10.1177\/03946320241303860","volume":"38","author":"JH Kim","year":"2024","unstructured":"Kim JH, Kwack MH, Lee WJ (2024) Effects of antioxidants on skin hydration, inflammatory cytokines, and keratinocyte differentiation markers in a PM(10)-exposed skin barrier-disrupted mouse model. Int J Immunopathol Pharmacol 38:3946320241303860","journal-title":"Int J Immunopathol Pharmacol"},{"key":"11529_CR111","doi-asserted-by":"publisher","first-page":"117321","DOI":"10.1016\/j.biopha.2024.117321","volume":"179","author":"J Gao","year":"2024","unstructured":"Gao J, Li D, Feng Z, Zhu X, Yang F, Zhang B et al (2024) Diterpenoid DGT alleviates atopic dermatitis\u2013like responses in vitro and in vivo via targeting IL-4R\u03b1. Biomed Pharmacother 179:117321","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"11529_CR112","doi-asserted-by":"publisher","first-page":"22132","DOI":"10.1038\/s41598-020-79301-2","volume":"10","author":"KH Lee","year":"2020","unstructured":"Lee KH, Lee JP, Kim W (2020) Effects of a complex mixture prepared from agrimonia, houttuynia, licorice, peony, and phellodendron on human skin cells. Sci Rep 10(1):22132","journal-title":"Sci Rep"},{"issue":"6","key":"11529_CR113","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5483\/BMBRep.2022.55.6.144","volume":"55","author":"Y Kwon","year":"2022","unstructured":"Kwon Y, Cho SY, Kwon J, Hwang M, Hwang H, Kang YJ et al (2022) Anti-atopic dermatitis effects of parasenecio auriculatus via simultaneous Inhibition of multiple inflammatory pathways. BMB Rep 55(6):275\u2013280","journal-title":"BMB Rep"},{"issue":"1","key":"11529_CR114","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12906-021-03259-5","volume":"21","author":"J Bajgai","year":"2021","unstructured":"Bajgai J, Xingyu J, Fadriquela A, Begum R, Kim DH, Kim CS et al (2021) Effects of mineral complex material treatment on 2,4- dinitrochlorobenzene-induced atopic dermatitis like-skin lesions in mice model. BMC Complement Med Ther 21(1):82","journal-title":"BMC Complement Med Ther"},{"issue":"2","key":"11529_CR115","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000518517","volume":"35","author":"SH Lim","year":"2022","unstructured":"Lim SH, Kim EJ, Lee CH, Park GH, Yoo KM, Nam SJ et al (2022) A lipid mixture enriched by ceramide NP with fatty acids of diverse chain lengths contributes to restore the skin barrier function impaired by topical corticosteroid. Skin Pharmacol Physiol 35(2):112\u2013123","journal-title":"Skin Pharmacol Physiol"},{"key":"11529_CR116","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2147\/CCID.S514527","volume":"18","author":"X Wang","year":"2025","unstructured":"Wang X, Mao D, Mu Z (2025) IL-4, IL-13, TNF-\u03b1 and IFN-\u03b3 downregulate CLDN8 expression through activating JAK signaling pathway in HaCaT cells. Clin Cosmet Investig Dermatol 18:999\u20131009","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"11529_CR117","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1159\/000479443","volume":"42","author":"Y Bai","year":"2017","unstructured":"Bai Y, Xu R, Zhang X, Zhang X, Hu X, Li Y et al (2017) Differential role of Rapamycin in Epidermis-Induced IL-15-IGF-1 secretion via activation of Akt\/mTORC2. Cell Physiol Biochem 42(5):1755\u20131768","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"11529_CR118","doi-asserted-by":"publisher","first-page":"e70195","DOI":"10.1111\/jocd.70195","volume":"24","author":"KC Kwon","year":"2025","unstructured":"Kwon KC, Kim MJ, Yoon SA (2025) Nanovesicles for sensitive skin care developed via Self-Assembly of glutamine linoleate. J Cosmet Dermatol 24(4):e70195","journal-title":"J Cosmet Dermatol"},{"key":"11529_CR119","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.2147\/IJN.S330716","volume":"16","author":"F Rancan","year":"2021","unstructured":"Rancan F, Guo X, Rajes K, Sidiropoulou P, Zabihi F, Hoffmann L et al (2021) Topical delivery of Rapamycin by means of Microenvironment-Sensitive Core-Multi-Shell nanocarriers: assessment of Anti-Inflammatory activity in an ex vivo Skin\/T cell Co-Culture model. Int J Nanomed 16:7137\u20137151","journal-title":"Int J Nanomed"},{"key":"11529_CR120","doi-asserted-by":"publisher","first-page":"102140","DOI":"10.1016\/j.nano.2019.102140","volume":"24","author":"A Badihi","year":"2020","unstructured":"Badihi A, Fru\u0161i\u0107-Zlotkin M, Soroka Y, Benhamron S, Tzur T, Nassar T et al (2020) Topical nano-encapsulated cyclosporine formulation for atopic dermatitis treatment. Nanomedicine 24:102140","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"11529_CR121","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2009.10.033","volume":"385","author":"G Mattheolabakis","year":"2010","unstructured":"Mattheolabakis G, Lagoumintzis G, Panagi Z, Papadimitriou E, Partidos CD, Avgoustakis K (2010) Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses. Int J Pharm 385(1\u20132):187\u2013193","journal-title":"Int J Pharm"},{"issue":"23","key":"11529_CR122","doi-asserted-by":"publisher","first-page":"13178","DOI":"10.3390\/ijms252313178","volume":"25","author":"S Park","year":"2024","unstructured":"Park S, Yang J, Sun K, Park S, Lee J, Kim S et al (2024) Dictamnus dasycarpus Turcz. Root bark improves skin barrier function and symptoms of atopic dermatitis in mice. Int J Mol Sci 25(23):13178","journal-title":"Int J Mol Sci"},{"key":"11529_CR123","doi-asserted-by":"crossref","unstructured":"Jiao S, Deng L, Niu M, Yang J (2025) Restorative effects of camellia oil on the skin-barrier function in a model of DNCB-induced atopic dermatitis. Eur J Histochem. ;69(1)","DOI":"10.4081\/ejh.2025.4147"},{"issue":"1","key":"11529_CR124","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/bjd.18476","volume":"182","author":"MJ Cork","year":"2020","unstructured":"Cork MJ, Tha\u00e7i D, Eichenfield LF, Arkwright PD, Hultsch T, Davis JD et al (2020) Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension. Br J Dermatol 182(1):85\u201396","journal-title":"Br J Dermatol"},{"issue":"5","key":"11529_CR125","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/bjd.19460","volume":"184","author":"MJ Cork","year":"2021","unstructured":"Cork MJ, Tha\u00e7i D, Eichenfield LF, Arkwright PD, Sun X, Chen Z et al (2021) Dupilumab provides favourable long-term safety and efficacy in children aged\u2009\u2265\u20096 to <\u200912 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study. Br J Dermatol 184(5):857\u2013870","journal-title":"Br J Dermatol"},{"issue":"5","key":"11529_CR126","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"M de Bruin-Weller","year":"2018","unstructured":"de Bruin-Weller M, Tha\u00e7i D, Smith CH, Reich K, Cork MJ, Radin A et al (2018) Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAF\u00c9). Br J Dermatol 178(5):1083\u20131101","journal-title":"Br J Dermatol"},{"issue":"1","key":"11529_CR127","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bjd.18565","volume":"183","author":"N Katoh","year":"2020","unstructured":"Katoh N, Kataoka Y, Saeki H, Hide M, Kabashima K, Etoh T et al (2020) Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials. Br J Dermatol 183(1):39\u201351","journal-title":"Br J Dermatol"},{"issue":"4","key":"11529_CR128","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/bjd.20690","volume":"186","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wu L, Lu Q, Gao X, Zhu X, Yao X et al (2022) The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 186(4):633\u2013641","journal-title":"Br J Dermatol"},{"issue":"12","key":"11529_CR129","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1111\/cts.13656","volume":"16","author":"J Wang","year":"2023","unstructured":"Wang J, White J, Sansone KJ, Spelman L, Sinclair R, Yang X et al (2023) Rademikibart (CBP-201), a next-generation monoclonal antibody targeting human IL-4R\u03b1: two phase I randomized trials, in healthy individuals and patients with atopic dermatitis. Clin Transl Sci 16(12):2614\u20132627","journal-title":"Clin Transl Sci"},{"issue":"5","key":"11529_CR130","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40259-024-00668-z","volume":"38","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Li JY, Yang B, Ding YF, Wu LM, Zhang LT et al (2024) Long-Term efficacy and safety of Stapokibart in adults with Moderate-to-Severe atopic dermatitis: an Open-Label Extension, nonrandomized clinical trial. BioDrugs 38(5):681\u2013689","journal-title":"BioDrugs"},{"issue":"1","key":"11529_CR131","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000350486","volume":"162","author":"SR Iyengar","year":"2013","unstructured":"Iyengar SR, Hoyte EG, Loza A, Bonaccorso S, Chiang D, Umetsu DT et al (2013) Immunologic effects of Omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial. Int Arch Allergy Immunol 162(1):89\u201393","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"11529_CR132","first-page":"133","volume":"28","author":"ML Roberti","year":"2014","unstructured":"Roberti ML, Ricottini L, Capponi A, Sclauzero E, Vicenti P, Fiorentini E et al (2014) Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgaris. J Biol Regul Homeost Agents 28(1):133\u2013139","journal-title":"J Biol Regul Homeost Agents"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11529-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11529-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11529-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:04:07Z","timestamp":1770289447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11529-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11529"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11529-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"F.K. and A.M. conceived and designed the manuscript. F.K. and A.M. wrote the manuscript. F.K. and A.M. methodology and drew the figures. F.K. and A.M. revised the manuscript. P.G. supervision.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contributions"}},{"value":"During the preparation of this work the authors used ChatGPT and DeepSeek in order to check for grammar mistakes and to improve the readability of the work. After using this tool\/service, the authors reviewed and edited the content as needed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of large Language models, AI and machine learning tools"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval,<!--Emphasis Type='Bold' removed-->consent to participate"}}],"article-number":"367"}}